Saesco Medical Expands European Presence with Miura Partners Backing
Deal News | May 09, 2025 | Miura Partners
Miura Partners has invested in Saesco Medical, a key player in the distribution of medical devices for minimally invasive surgery across Europe. As part of the investment, the acquisition of Cardiolink, a specialist distributor in the Iberian Peninsula, has been completed. This strategic move enhances Saesco's presence in clinical and hospital sectors, particularly in Spain and Portugal. Saesco Medical, founded in Barcelona, operates directly in five European countries and has a broad commercial reach, serving over 2,000 healthcare providers with an extensive product portfolio. The partnership with Miura Partners, which has a significant track record in scaling healthcare businesses in Europe, aims to drive Saesco's international expansion strategy, emphasizing innovation and minimally invasive surgery. The transaction also involves a capital increase to bolster Saesco's growth and consolidation initiatives. Key advisory roles in the transaction were played by Aquilon Partners, AZ Capital, Cuatrecasas, Deloitte, and Roland Berger.
Sectors
- Medical Devices
- Private Equity
- Healthcare
Geography
- Europe – The article centers around Saesco Medical and Cardiolink's operations in several European countries, marking their influence in the region's medical device sector.
- Spain – Both Saesco Medical and Cardiolink are headquartered in Spain, and their operations significantly impact the Spanish healthcare market.
- Portugal – The acquisition of Cardiolink enhances Saesco Medical's presence in Portugal as part of its Iberian expansion strategy.
Industry
- Medical Devices – Involves the distribution and development of devices used for minimally invasive surgeries and other medical procedures, which is central to Saesco Medical's and Cardiolink's business.
- Private Equity – Miura Partners operates in this sector by investing in Saesco Medical to drive its growth and expansion in the healthcare market.
- Healthcare – The companies involved provide medical solutions and equipment, emphasizing innovation and minimally invasive surgical procedures.
Financials
- Over 50 million – Combined turnover of Saesco Medical and Cardiolink post acquisition.
- 1.5 billion – Total assets under management by Miura Partners.
- 4 billion – Value of investments completed by Miura Partners.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Saesco Medical | Target company | Company | A European distributor of medical devices specializing in minimally invasive surgery. |
| Miura Partners | Investor | Company | A Private Equity firm investing in Saesco Medical to support its growth and internationalization. |
| Cardiolink | Acquired company | Company | A Spanish firm specializing in the distribution of medical devices, now part of the Saesco Group. |
| Aquilon Partners | Financial Advisor | Company | Provided financial advice for the transaction. |
| AZ Capital | Financial Advisor | Company | Provided financial advisory services for the deal. |
| Cuatrecasas | Legal Advisor | Company | Offered legal services for the transaction. |
| Deloitte | Legal Advisor | Company | Provided legal advice related to the acquisition. |
| Roland Berger | Commercial Advisor | Company | Provided commercial advice for the deal. |
| Jordi Fluvi | CEO of Saesco Medical | Person | Founder and CEO of Saesco Medical, leading its strategic initiatives. |
| Carlos Juli | Partner | Person | A partner at Miura Partners involved in the Saesco investment. |